Independent register of U.S. FDA drug recalls · updated Oct 12, 2026
RxRecalls Get alerts

Sterility & contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections.

6,317 FDA drug recalls with this cause, newest first.

This is the single biggest cause in the register by a wide margin. It covers products that had to be sterile - injectables, eye drops, certain ointments - but could not be verified sterile, or were found contaminated during testing. Most of these recalls come from compounding pharmacies and outsourcing facilities after an FDA inspection finds gaps in how sterile products were made. Sterility failures are treated seriously because the products involved have the least room for error, going straight into the bloodstream or the eye.

Class II · Moderate risk

Methyl-Cobalamin injectable

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Terminated Sterility / contamination Auro Pharmacies, Inc. D-1162-2018
Class II · Moderate risk

Methyl-Cobalamin injectable

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Terminated Sterility / contamination Auro Pharmacies, Inc. D-1161-2018
Class II · Moderate risk

Methyl-Cobalamin injectable

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Terminated Sterility / contamination Auro Pharmacies, Inc. D-1160-2018
Class II · Moderate risk

Glutathione injectable

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Terminated Sterility / contamination Auro Pharmacies, Inc. D-1159-2018
Class II · Moderate risk

Dexpanthenol injectable

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Terminated Sterility / contamination Auro Pharmacies, Inc. D-1158-2018
Class II · Moderate risk

Calcium Gluconate injectable

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Terminated Sterility / contamination Auro Pharmacies, Inc. D-1157-2018
Class II · Moderate risk

CoEnzyme-Q10 injectable

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Terminated Sterility / contamination Auro Pharmacies, Inc. D-1156-2018
Class II · Moderate risk

Papav 300/Phent 5mg/10mL

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Terminated Sterility / contamination Ranier's Compounding Laboratory D-1094-2018
Class II · Moderate risk

P/P/P 0.02/40/2mg/mL

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Terminated Sterility / contamination Ranier's Compounding Laboratory D-1093-2018
Class II · Moderate risk

PRO/PA/PH/AT 18mcg/1.8mg/

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Terminated Sterility / contamination Ranier's Compounding Laboratory D-1092-2018
Class II · Moderate risk

PRASH 12.2mcg/1.22m/19.29

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Terminated Sterility / contamination Ranier's Compounding Laboratory D-1091-2018